These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18782047)

  • 1. Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents.
    Foroumadi A; Safavi M; Emami S; Siavoshi F; Najjari S; Safari F; Shafiee A
    Med Chem; 2008 Sep; 4(5):498-502. PubMed ID: 18782047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Substituted-5-nitroheterocycles: in vitro anti-Helicobacter pylori activity and structure-activity relationship study.
    Foroumadi A; Sorkhi M; Moshafi MH; Safavi M; Rineh A; Siavoshi F; Shafiee A; Emami S
    Med Chem; 2009 Nov; 5(6):529-34. PubMed ID: 19673692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of New Nitrofluoroquinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant H. pylori.
    Abu-Qatouseh L; Abu-Sini M; Mayyas A; Al-Hiari Y; Darwish R; Aburjai T
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
    Moshafi MH; Sorkhi M; Emami S; Nakhjiri M; Yahya-Meymandi A; Negahbani AS; Siavoshi F; Omrani M; Alipour E; Vosooghi M; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):178-83. PubMed ID: 21384417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori.
    Abu-Sini M; Mayyas A; Al-Karablieh N; Darwish R; Al-Hiari Y; Aburjai T; Arabiyat S; Abu-Qatouseh L
    Molecules; 2017 May; 22(5):. PubMed ID: 28531095
    [No Abstract]   [Full Text] [Related]  

  • 7. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.
    Chimenti F; Bizzarri B; Manna F; Bolasco A; Secci D; Chimenti P; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
    Bioorg Med Chem Lett; 2005 Feb; 15(3):603-7. PubMed ID: 15664821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
    Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
    J Med Chem; 2000 Aug; 43(17):3315-21. PubMed ID: 10966750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.
    Foroumadi A; Rineh A; Emami S; Siavoshi F; Massarrat S; Safari F; Rajabalian S; Falahati M; Lotfali E; Shafiee A
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3315-20. PubMed ID: 18442909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
    Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
    Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
    Sakurai N; Sano M; Hirayama F; Kuroda T; Uemori S; Moriguchi A; Yamamoto K; Ikeda Y; Kawakita T
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2185-90. PubMed ID: 9873510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Structure-Activity Relationship of Palmatine Derivatives as a Novel Class of Antibacterial Agents against
    Fan T; Guo X; Zeng Q; Wei W; You X; Wang Y; Pang J; Song D
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32188132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone.
    Klesiewicz K; Karczewska E; Budak A; Marona H; Szkaradek N
    J Antibiot (Tokyo); 2016 Nov; 69(11):825-834. PubMed ID: 27025351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles.
    Katsura Y; Nishino S; Tomishi T; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1307-12. PubMed ID: 9871756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
    Katsura Y; Nishino S; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
    J Med Chem; 2002 Jan; 45(1):143-50. PubMed ID: 11754586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
    Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
    Chang CS; Liu JF; Lin HJ; Lin CD; Tang CH; Lu DY; Sing YT; Chen LY; Kao MC; Kuo SC; Lai CH
    Eur J Med Chem; 2012 Feb; 48():244-54. PubMed ID: 22217866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.